Skip to content

Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern India

Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern India

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01629771
Enrollment
72
Registered
2012-06-28
Start date
2012-05-31
Completion date
2012-06-30
Last updated
2014-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphatic Filariasis

Brief summary

According to the World Health Organization, lymphatic filariasis, a mosquito-borne parasitic disease, is the second leading cause of disability worldwide. Across 81 countries, approximately 120 million people are infected with the disease, and of those infected, an estimated 40% reside in India alone. The most disfiguring symptoms of lymphatic filariasis, elephantiasis and lymphedema, cause long-term suffering in patients who are then often embarrassed or even rejected from their communities. Because of the disease's debilitating physical and social effects on patients, this study will explore the intersection of disability and health-related quality of life (HRQoL) in lymphatic filariasis patients in India. Specifically, HRQoL and disability in lymphatic filariasis subjects and age- and gender- matched control subjects will be compared. Two HRQoL tools , the general Dermatology Life Quality Index (DLQI) and a disease-specific instrument developed by a dermatology group in India will be used to gauge HRQol. In addition, the demographic and disease-specific factors associated with HRQoL and disability in filarial lymphedema subjects will be identified.

Interventions

None listed

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Case Inclusion Criteria * Subjects with a clinical diagnosis of lymphatic filariasis * Subjects over the age of 18 and able to give consent Case

Exclusion criteria

* Subjects on active treatment for lymphatic filariasis * Subjects who are under the age of 18 or unable to give informed consent Control Inclusion Criteria * Subjects without a clinical diagnosis of lymphatic filariasis * Subjects over the age of 18 and able to give consent Control

Design outcomes

Primary

MeasureTime frameDescription
Dermatology Life Quality Index (DLQI) Domain ScoresAssessed after enrollmentThe DLQI is a 10-item questionnaire measuring skin-specific quality of life through six domains: Symptoms & Feelings, Daily Activities, Leisure, Work & School, Personal Relationships, and Treatment. Symptoms & Feelings, Daily Activities, Leisure, and Personal Relationships are each scored from 0 to 3, where 0 is associated with no effect on a patient's life, and 3 is associated with a large effect on a patient's life. Work & School and Treatment are each scored from 0 to 3, where 0 is associated with no effect on a patient's life, and 6 is associated with a large effect on a patient's life.
Lymphatic Filariasis-Specific Quality of Life (LFSQQ) Domain ScoresAssessed after enrollmentThe LFSQQ was developed to assess quality of life in subjects with lymphatic filariasis through seven domains: Mobility, Self-Care, Usual Activities, Disease Burden, Pain/Discomfort, Psychological Health, and Social Participation. Items are scored on a 5-point scale (no problem, mild, moderate, severe, most severe), and scores for each domain are calculated based on the number of questions answered and the raw scores. Scores for each domain range from 0 to 100, where 0 is associated with a worse quality of life and 100 is associated with a better quality of life.
World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) Domain ScoresAssessed after enrollmentThe WHODAS 2.0 is a generic health and disability assessment tool that describes effects of disease on six domains: Cognition, Mobility, Self-Care, Getting Along, Life Activities, and Participation in Society. Responses are measured on a 5-point scale from 1 (no difficulty) to 5 (extreme difficulty or cannot do). Scores are calculated using a WHO SPSS 36 version syntax for employed subjects and a WHO SPSS 32 version syntax for unemployed subjects. Scores for each domain range from 0 to 100, where 0 is associated with no impairment of health status, and 100 is associated with a greater impairment of health status.

Countries

India, United States

Participant flow

Participants by arm

ArmCount
Subjects With Lymphatic Filariasis
Subjects with lymphatic filariasis completed health-related quality of life questionnaires.
36
Control Subjects
Age- and gender-matched control subjects completed health-related quality of life questionnaires.
36
Total72

Baseline characteristics

CharacteristicSubjects With Lymphatic FilariasisControl SubjectsTotal
Age, Continuous51.7 years
STANDARD_DEVIATION 16.2
52.3 years
STANDARD_DEVIATION 16.1
52.0 years
STANDARD_DEVIATION 16
Region of Enrollment
India
36 participants36 participants72 participants
Sex: Female, Male
Female
28 Participants28 Participants56 Participants
Sex: Female, Male
Male
8 Participants8 Participants16 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Dermatology Life Quality Index (DLQI) Domain Scores

The DLQI is a 10-item questionnaire measuring skin-specific quality of life through six domains: Symptoms & Feelings, Daily Activities, Leisure, Work & School, Personal Relationships, and Treatment. Symptoms & Feelings, Daily Activities, Leisure, and Personal Relationships are each scored from 0 to 3, where 0 is associated with no effect on a patient's life, and 3 is associated with a large effect on a patient's life. Work & School and Treatment are each scored from 0 to 3, where 0 is associated with no effect on a patient's life, and 6 is associated with a large effect on a patient's life.

Time frame: Assessed after enrollment

ArmMeasureGroupValue (MEDIAN)
Subjects With Lymphatic FilariasisDermatology Life Quality Index (DLQI) Domain ScoresSymptoms & Feelings3 units on a scale
Subjects With Lymphatic FilariasisDermatology Life Quality Index (DLQI) Domain ScoresDaily Activities1 units on a scale
Subjects With Lymphatic FilariasisDermatology Life Quality Index (DLQI) Domain ScoresLeisure1 units on a scale
Subjects With Lymphatic FilariasisDermatology Life Quality Index (DLQI) Domain ScoresWork & School0 units on a scale
Subjects With Lymphatic FilariasisDermatology Life Quality Index (DLQI) Domain ScoresPersonal Relationships0 units on a scale
Subjects With Lymphatic FilariasisDermatology Life Quality Index (DLQI) Domain ScoresTreatment0 units on a scale
Control SubjectsDermatology Life Quality Index (DLQI) Domain ScoresPersonal Relationships0 units on a scale
Control SubjectsDermatology Life Quality Index (DLQI) Domain ScoresSymptoms & Feelings0 units on a scale
Control SubjectsDermatology Life Quality Index (DLQI) Domain ScoresWork & School0 units on a scale
Control SubjectsDermatology Life Quality Index (DLQI) Domain ScoresDaily Activities0 units on a scale
Control SubjectsDermatology Life Quality Index (DLQI) Domain ScoresTreatment0 units on a scale
Control SubjectsDermatology Life Quality Index (DLQI) Domain ScoresLeisure0 units on a scale
Primary

Lymphatic Filariasis-Specific Quality of Life (LFSQQ) Domain Scores

The LFSQQ was developed to assess quality of life in subjects with lymphatic filariasis through seven domains: Mobility, Self-Care, Usual Activities, Disease Burden, Pain/Discomfort, Psychological Health, and Social Participation. Items are scored on a 5-point scale (no problem, mild, moderate, severe, most severe), and scores for each domain are calculated based on the number of questions answered and the raw scores. Scores for each domain range from 0 to 100, where 0 is associated with a worse quality of life and 100 is associated with a better quality of life.

Time frame: Assessed after enrollment

ArmMeasureGroupValue (MEDIAN)
Subjects With Lymphatic FilariasisLymphatic Filariasis-Specific Quality of Life (LFSQQ) Domain ScoresUsual Activities92 units on a scale
Subjects With Lymphatic FilariasisLymphatic Filariasis-Specific Quality of Life (LFSQQ) Domain ScoresPain/Discomfort90 units on a scale
Subjects With Lymphatic FilariasisLymphatic Filariasis-Specific Quality of Life (LFSQQ) Domain ScoresSelf-Care100 units on a scale
Subjects With Lymphatic FilariasisLymphatic Filariasis-Specific Quality of Life (LFSQQ) Domain ScoresPsychological Health75 units on a scale
Subjects With Lymphatic FilariasisLymphatic Filariasis-Specific Quality of Life (LFSQQ) Domain ScoresDisease Burden63 units on a scale
Subjects With Lymphatic FilariasisLymphatic Filariasis-Specific Quality of Life (LFSQQ) Domain ScoresSocial Participation67 units on a scale
Subjects With Lymphatic FilariasisLymphatic Filariasis-Specific Quality of Life (LFSQQ) Domain ScoresMobility67 units on a scale
Control SubjectsLymphatic Filariasis-Specific Quality of Life (LFSQQ) Domain ScoresSocial Participation100 units on a scale
Control SubjectsLymphatic Filariasis-Specific Quality of Life (LFSQQ) Domain ScoresMobility100 units on a scale
Control SubjectsLymphatic Filariasis-Specific Quality of Life (LFSQQ) Domain ScoresSelf-Care100 units on a scale
Control SubjectsLymphatic Filariasis-Specific Quality of Life (LFSQQ) Domain ScoresUsual Activities100 units on a scale
Control SubjectsLymphatic Filariasis-Specific Quality of Life (LFSQQ) Domain ScoresDisease Burden100 units on a scale
Control SubjectsLymphatic Filariasis-Specific Quality of Life (LFSQQ) Domain ScoresPain/Discomfort100 units on a scale
Control SubjectsLymphatic Filariasis-Specific Quality of Life (LFSQQ) Domain ScoresPsychological Health100 units on a scale
Primary

World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) Domain Scores

The WHODAS 2.0 is a generic health and disability assessment tool that describes effects of disease on six domains: Cognition, Mobility, Self-Care, Getting Along, Life Activities, and Participation in Society. Responses are measured on a 5-point scale from 1 (no difficulty) to 5 (extreme difficulty or cannot do). Scores are calculated using a WHO SPSS 36 version syntax for employed subjects and a WHO SPSS 32 version syntax for unemployed subjects. Scores for each domain range from 0 to 100, where 0 is associated with no impairment of health status, and 100 is associated with a greater impairment of health status.

Time frame: Assessed after enrollment

ArmMeasureGroupValue (MEDIAN)
Subjects With Lymphatic FilariasisWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) Domain ScoresCognition15 units on a scale
Subjects With Lymphatic FilariasisWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) Domain ScoresMobility50 units on a scale
Subjects With Lymphatic FilariasisWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) Domain ScoresSelf-Care5 units on a scale
Subjects With Lymphatic FilariasisWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) Domain ScoresGetting Along25 units on a scale
Subjects With Lymphatic FilariasisWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) Domain ScoresLife Activities20 units on a scale
Subjects With Lymphatic FilariasisWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) Domain ScoresParticipation in Society25 units on a scale
Control SubjectsWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) Domain ScoresLife Activities0 units on a scale
Control SubjectsWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) Domain ScoresCognition0 units on a scale
Control SubjectsWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) Domain ScoresGetting Along0 units on a scale
Control SubjectsWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) Domain ScoresMobility0 units on a scale
Control SubjectsWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) Domain ScoresParticipation in Society0 units on a scale
Control SubjectsWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) Domain ScoresSelf-Care0 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026